Second-Level Professor, Chief Physician; Doctoral Supervisor; Vice President of the Clinical Research Institute at the First Affiliated Hospital of Jinan University, Director of the Department of Psychiatry, and Director of the Sleep Medicine Center.

• From January 1996 to January 1999, he studied at the Anxiety Disorders Department of the Psychiatry Department at Massachusetts General Hospital, affiliated with Harvard University, under the guidance of Professor Michael Jenike, focusing on the diagnosis and treatment of obsessive-compulsive disorder and anxiety disorders. He also conducted postdoctoral research at the University of Texas Southwestern Medical Center under the mentorship of the world-renowned depression expert Professor A. John Rush (Chair of the DSM-IV Mood Disorders Diagnostic Criteria Working Group and Principal Investigator of the STAR*D Antidepressant Treatment Study). His research focused on the psychobiology of depressive disorders and the efficacy of antidepressant medications.

• 
  

• In 2003, he received a scholarship from the American Academy of Sleep Medicine and underwent clinical training in sleep medicine at the Sleep Center of the University of Pennsylvania School of Medicine, studying under the guidance of the world-renowned sleep expert Professor Alan Pack to learn clinical diagnostic and treatment techniques for sleep disorders.

• 
  

• His current clinical research focuses on the psychobiology and clinical pharmacology of sleep disorders, depressive disorders, bipolar disorder, and anxiety disorders.

1978.09-1981.06: Jiangxi Yichun University Medical College, Clinical Medicine, Bachelor's Degree, Supervisor: None

1986-1989: Master's Degree at Sun Yat-sen University of Medical Sciences

January 1996 - April 1996: Visiting Scholar at the Psychiatry Department of Massachusetts General Hospital, Harvard Medical School, Supervisor: Michael Jenike

May 1996 - January 1999: Postdoctoral Researcher at the Psychiatry Department of the University of Texas Southwestern Medical Center, Supervisor: John Rush

September 1989 - December 1995: Resident Physician and Lecturer, Department of Psychiatry, The Third Affiliated Hospital of Sun Yat-sen University.

February 1999 - December 2004: Attending Physician, Department of Psychiatry, The Third Affiliated Hospital of Sun Yat-sen University; Promoted to Associate Professor and Associate Chief Physician in 2001.

January 2005 - September 2007: Director of the Department of Psychiatry and Sleep Medicine Center, Director of the Teaching and Research Section, Associate Professor, and Chief Physician, The First Affiliated Hospital of Jinan University.

October 2007 - March 2021: Director of the Department of Psychiatry and Sleep Medicine Center, Director of the Teaching and Research Section, Professor, Chief Physician, and Doctoral Supervisor, The First Affiliated Hospital of Jinan University.

April 2021 - Present: Vice President of the Clinical Research Institute of Jinan University, Director of the Department of Psychiatry and Sleep Medicine Center, The First Affiliated Hospital of Jinan University; Professor, Chief Physician, and Doctoral Supervisor.

1. Diagnosis and treatment of various refractory depressions, bipolar disorders, anxiety disorders, obsessive-compulsive disorders, and trauma-related stress disorders.

2. Diagnosis and treatment of various refractory insomnias and other sleep disorders.

3. Diagnosis and treatment of depression, anxiety, bipolar disorders, and sleep disorders in children, adolescents, and the elderly.

4. Diagnosis and treatment of eating disorders; drug dependence and other addiction diseases.

1.    Negative perfectionism and sleep quality in Chinese international students under COVID-19 epidemic: A moderated mediation.《Front Psychol》 Zhaoyang H, Feng C, Mei F, Jingjing L, Pan J.

2.    Correlation Between Serum High-Sensitivity C-Reactive Protein, Tumor Necrosis Factor-Alpha, Serum Interleukin-6 and White Matter Integrity Before and After the Treatment of Drug-Naïve Patients With Major Depressive Disorder《Front Neurosci》Chen L, Zeng X, Zhou S, Gu Z, Pan J.

3.    Influencing factors of obesity in community patients with deficit schizophrenia: a cross-sectional study.《Eur J Med Res》Yong N, Pan J, Li X, Yu L, Hou X.

4.    A two-center radiomic analysis for differentiating major depressive disorder using multi-modality MRI data under different parcellation methods. 《J Affect Disord》Sun K, Liu Z, Chen G, Zhou Z, Zhong S, Tang Z, Wang S, Zhou G, Zhou X, Shao L, Ye X, Zhang Y, Jia Y, Pan J, Huang L, Liu X, Liu J, Tian J, Wang Y.

5.    Liu B, Huang L, Liu Z, Pan X, Cui Z, Pan J, Xie L. EasyMicroPlot: An Efficient and Convenient R Package in Microbiome Downstream Analysis and Visualization for Clinical Study. Front Genet. 2022 Jan 4;12:803627. (IF=4.599).

6.    Xiang T, Cai Y, Hong Z, Pan J. Efficacy and safety of Zolpidem in the treatment of insomnia disorder for one month: a meta-analysis of a randomized controlled trial. Sleep Med. 2021; 87:250-256. (IF=3.492)

7.    Zhang L, Pan R, Pan J. The Prevalence of Post-Traumatic Stress Disorder in the General Population during the COVID-19 Pandemic: A Systematic Review and Single-Arm Meta-Analysis[J]. Psychiatry Investig. 2021;18(5):426-433. (IF=2.505)

8.    Jin-Feng Wen, Xin-wen Guo, Ji-Yang Pan, et al. A PET imaging study of the brain changes of glucose metabolism in patients with temporal lobe epilepsy and depressive disorder[J]. BMC Medical Imaging, 2021, 21(1). (IF= 1.930)

9.   Yu J, Xiang T, Pan J. The Relationship between Dysfunctional Beliefs and Attitudes about Sleep and Sleep Structure in Patients with Insomnia: A Controlled Study[J]. Psychology, 2020, 11(3):541-549.（IF=1.27）

10.   Dai J, Pan J-Y, Liao N et al. Influence of miR-155 on behaviors of depression mice through regulating Wnt/β-catenin signaling pathway [J]. Eur Rev Med Pharmacol Sci, 2020, 24: 1398-1407.（IF=3.024）

11.    Gu Zhiwen, Pan Jiyang, Chen Liping. MiR-124 suppression in the prefrontal cortex reduces depression-like behavior in mice[J]. Biosci Rep, 2019, 39: undefined.（IF=2.942）

12.   Luo Xu-Dong, Feng Jin-Shan, Pan Ji-yang, et al. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis[J]. BMC Psychiatry, 2020, 20: 248.（IF=2.704）

13.   Pan R, Zhang L, Pan J. The Anxiety Status of Chinese Medical Workers During the Epidemic of COVID-19: A Meta-Analysis[J]. Psychiatry investigation, 2020, 17(5). (IF=2.505)

14.   Gu, Zhiwen; Pan Jiyang, Chen, Liping. MiR-124 suppression in the prefrontal cortex reduces depression-like behavior in mice[J]. Bioscience Reports, 2019, 39(9). (IF=2.942)

15.   Liu B, Lin W, Pan J, et al. Gut Microbiota as a Subjective Measurement for Auxiliary Diagnosis of Insomnia Disorder[J]. other, 2019, 10. (IF=4.235)

16.   Pan X, Liu B, Pan J, et al. Nr4a1 as a myogenic factor is upregulated in satellite cells/myoblast under proliferation and differentiation state[J]. Biochemical and Biophysical Research Communications, 2019. (IF=2.958)

17.   Huang Q, Ye X, Pan J, et al. Salvianolic acid B abolished chronic mild stress‐induced depression through suppressing oxidative stress and neuro‐inflammation via regulating NLRP3 inflammasome activation[J]. Journal of Food Biochemistry, 2019, 43(3). （IF=1.662）

18.   Liping C, Chunliu L, Pan J, et al. Excessive daytime sleepiness in general hospital nurses: prevalence, correlates, and its association with adverse events[J]. Sleep And Breathing, 2018, 23:1-8. （IF=2.162）

19.   Luo C, Zhang J, Pan J, et al. Course, risk factors, and mental health outcomes of excessive daytime sleepiness in rural Chinese adolescents: A one-year prospective study[J]. J Affect Disord, 2018, 231:15-20. （IF=3.892）

20.   Wang Y, Zhong S, Pan J, et al. Disrupted Resting-State Functional Connectivity in Nonmedicated Bipolar Disorder[J]. Radiology, 2016:529. （IF=7.931）

21.   Wang S, Pan J. Irisin ameliorates depressive-like behaviors in rats by regulating energy metabolism[J]. Biochemical and Biophysical Research Communications, 2016. （IF=2.985）

• Clinical Diagnosis and Treatment of Sleep Disorders (Edited by Professor Pan Jiyang, South China University of Technology Press, 2001, the first sleep medicine monograph in China)

• Sleep Medicine (First and Second Editions) (Associate Editor: Professor Pan Jiyang, People's Medical Publishing House, 13th Five-Year Plan textbook, 2016, 2022)

• Psychiatry (Second Edition) (Contributor: Professor Pan Jiyang, Fudan University Press, 2009)

• Advances in Psychiatry (Contributor: Professor Pan Jiyang, Peking Union Medical College Press, 2010)

• Psychiatry (Second Edition) (Contributor: Professor Pan Jiyang, Peking University Medical Press, 2010)

• Essential Psychopharmacology: A Prescription Guide (Second Edition) (Translator: Professor Pan Jiyang, Peking University Medical Press, 2009)

• Principles and Practice of Sleep Medicine (Fourth Edition) (Translator: Professor Pan Jiyang, People's Medical Publishing House, 2010)

• Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (Third Edition) (Translator: Professor Pan Jiyang, Peking University Medical Press, 2011)

• International Classification of Sleep Disorders (Third Edition) (Translator: Professor Pan Jiyang, People's Medical Publishing House, 2017)

1. National Natural Science Foundation of China (General Program): Molecular Mechanisms of Gut Microbiota-Mediated β-Hydroxybutyrate Regulation of BDNF-TrkB Signaling Pathway Affecting GABA Production in Brain Tissue and REM Sleep in Insomnia Disorder, 2019/01-2022/12, Principal Investigator. Funding: 610,000 RMB.

2. National Key R&D Program of China Research on Prevention and Treatment of Common Multimorbidities: Sub-project Construction of Insomnia Disorder Cohort and Multimodal Digital Assessment Platform, 2022/01-2024/12, Participant (Sub-center Leader), Funding: 300,000 RMB.

3. National Key R&D Program of China Research on Prevention and Treatment of Common Multimorbidities: Intelligent Diagnosis and Treatment Model for Insomnia Disorder and Its Efficacy Evaluation, 2023/01-2025/12, Sub-project Leader, Funding: 3,860,000 RMB.

4. Guangzhou Science and Technology Plan Project: Early Diagnosis of Adolescent Bipolar Disorder Based on Gut Microbiota and Sleep-Wake Cycle, 2019/04-2022/03, Principal Investigator.

1. Guangdong Natural Science Foundation: Mechanisms and Neural Basis of Decision-Making Behavior Under Information Overload in the Internet Environment, 2017/07/05-2020/05/01, Participant (Sub-center Leader).

2. Guangdong Natural Science Foundation: Mechanisms of Gut Microbiota in Hyperactivity of the Hypothalamic-Pituitary-Adrenal Axis in Insomnia Disorder, 2017/07-2020/05, Principal Investigator.

3. Guangzhou Science and Technology Plan Project: Association Between Central Cholinergic Complex, N-Acetylaspartate Metabolism Levels, and Peripheral Neuropeptide Y, Substance P in Bipolar Depressive Disorder, 2014/01-2015/12, Principal Investigator.

4. Guangdong Science and Technology Plan Project: Clinical Characteristics and Pathogenesis of Non-Restorative Sleep, 2013/06-2015/05, Principal Investigator.

5. National Natural Science Foundation of China (General Program): Physiological Mechanisms of Sleep Disorders (Insomnia) and the Utility of Happiness Experience, 2013/01-2016/12, Participant.

6. Tianhe District Science and Technology Bureau, Guangzhou: Study on Physical Health, Sleep, and Emotional Status of Leading Cadres in Tianhe District, Guangzhou, 2010/07-2012/06, Principal Investigator.

1. International Multicenter Collaboration Project with the University of Oxford: Study on Unipolar Depressive Disorder in Women (CONVERGE), 2009/06-2015/06 (Completed), Principal Investigator.

2. Guangdong Science and Technology Plan Project: Mechanisms of Brain Neuropeptide Y System in the Anxiolytic Effects of Caffeine and Theobromine, 2010/01-2011/12, Principal Investigator.

3. Ministry of Science and Technology of China: Evaluation of Comprehensive Traditional Chinese Medicine Interventions for Subhealth Insomnia and Methodological Research, 2006/09-2009/10, Principal Investigator.

4. Guangdong Natural Science Foundation: Effects of Leptin and Neuropeptide Y on Anxiety Behavior Induced by REM Sleep Deprivation, 2007/10-2008/12, Principal Investigator.

5. Guangdong Science and Technology Plan Project: Study on Risk Factors and Predictive Models for Chronic Insomnia, 2007/01-2008/12, Principal Investigator.

6. Wu Jieping Medical Foundation Health Sleep Fund: Effects of REM Sleep Deprivation on Serum Leptin and Hypothalamic Leptin Levels in Rats, 2007/01-2008/12.

7. Startup Fund for Scientific Research Talents, The First Affiliated Hospital of Jinan University: Anxiolytic Effects of Ginkgo Biloba Extract and Its Material Basis, 2006/01-2007/12, Principal Investigator.

1. Guangdong Science and Technology Plan Project: Study on the Predictive Role of 5-HTT Gene Polymorphisms in Antidepressant Treatment Response, 2004/01-2006/12, Principal Investigator.

Psychiatry Undergraduate Course, The First Clinical Medical College of Jinan University.

• Vice Chairman, Sleep Medicine Committee, Chinese Medical Doctor Association.

• Committee Member, Depression and Bipolar Disorder Committee, Psychiatric Physician Branch, Chinese Medical Doctor Association.

• Standing Committee Member, Psychosomatic Medicine Branch, Chinese Medical Association; Leader, Sleep Disorders Collaborative Group; Deputy Leader, Anxiety Disorders Group.

• Member, Psychopharmacology Group, Bipolar Disorder Group, and Anxiety Disorders Collaborative Group, Chinese Medical Association.

• Committee Member, Sleep Disorders Group, Neurology Branch, Chinese Medical Association.

• Standing Committee Member, Sleep Disorders Committee, Chinese Sleep Research Society.

• Vice Chairman, Sleep Medicine Branch, Chinese Stroke Association.

• Vice Chairman, Sleep Disorders Rehabilitation Committee, Chinese Rehabilitation Medical Association.

• Expert, Teaching Guidance Committee for Psychiatry, Ministry of Education.

• Review Expert, National Medical Products Administration.

• Member, American Academy of Sleep Medicine (AASM).

• Member, American Society for Clinical Pharmacology and Therapeutics (ASCPT).

• Member, International Society for Bipolar Disorders (ISBD).

• Vice Chairman, Psychiatry Branch, Guangdong Medical Association; Leader, Psychopharmacology Group.

• Deputy Leader, Pharmacotherapy Group, Psychiatric Physician Branch, Guangdong Medical Doctor Association.

• President, Sleep Disorders and Mental Health Branch, Guangdong Community Health Association.